Prosthetic joint loosening due to Brucella spp. is a rare event. In this report, we describe a rare case of prosthetic infection caused by brucella. A 71-year-old woman reported a six-month history of progressing pain in the right prosthetic knee, which had been implanted for arthrosis four years prior to admission, associated with fever. No night sweats were noted. On examination, the right knee appeared slightly swollen and painful on mobilization, and the surgical wound was normal. Blood tests showed increased C-Reactive Protein (CRP) (34mg/L) and erythrocyte sedimentation rate (ESR) (34mm/hr). A CT scan of her right knee was performed, showing loosening of the prosthesis, joint effusion, and osteolysis in contact with the internal tibial component measuring 16mm maximum with bone remodeling of the epiphysis and metaphysis regions. Rose Bengal test was positive for brucellosis, a standard brucella tube agglutination test was positive at a titer of 1/80, blood cultures for brucella were negative and a PCR for detection of Mycobacterium tuberculosis was negative. The patient was diagnosed as having Brucella infection of his total knee arthroplasty. Favorable outcome was observed after medical and surgical treatment. We believe this is the first detailed report of Brucella prosthetic infection in the country despite the endemicity of this type of zoonosis.
Introduction: Disseminated invasive aspergillosis is a rare but life-threatening fungal infection that predominantly affects immunocompromised individuals. Vertebral involvement is an uncommon manifestation, and diagnosis in immunocompetent patients is particularly challenging because of its nonspecific clinical and radiological features, often resulting in delayed diagnosis and inappropriate therapy. We report a fatal case of disseminated Aspergillus flavus aspergillosis presenting as spondylodiscitis in an immunocompetent host, highlighting the diagnostic challenges and therapeutic implications. Case description: A 54-year-old man with no recognized immunosuppressive condition presented with a five-month history of progressive dorsolumbar pain complicated by paraparesis. Magnetic resonance imaging demonstrated thoracic spondylodiscitis with extensive epidural and paravertebral abscesses. Histopathological examination of the discovertebral biopsy initially suggested tuberculous spondylodiscitis, leading to empirical antituberculous therapy and corticosteroid administration. Mycological culture and periodic acid–Schiff staining subsequently identified an Aspergillus section Flavi isolate phenotypically identified as Aspergillus flavus , establishing the diagnosis of Aspergillus spondylodiscitis. Empirical antifungal therapy with amphotericin B deoxycholate was initiated and later switched to voriconazole after antifungal susceptibility testing showed reduced in vitro susceptibility to amphotericin B and an elevated echinocandin minimum effective concentration, with preserved susceptibility to voriconazole. Additional investigations, including compatible cross-sectional imaging findings and a positive serum galactomannan antigen assay, supported presumed pulmonary and sphenoidal sinus involvement in addition to proven vertebral disease with extension to the adjacent ribs. Evaluation of host immunity revealed negative HIV serology and a preserved CD4 T-lymphocyte count (902 cells/µL), with no identifiable underlying risk factors. Despite targeted antifungal therapy, the patient experienced progressive neurological deterioration due to spinal cord compression, requiring emergency decompressive laminectomy. He subsequently developed postoperative septic shock and died. Conclusion: This case underscores that invasive aspergillosis should be considered in the differential diagnosis of chronic or subacute spondylodiscitis, even in apparently immunocompetent patients. Early diagnosis requires vertebral biopsy with dedicated fungal histopathology, mycological culture, species identification, and antifungal susceptibility testing to enable timely targeted therapy and early multidisciplinary management.
Background Staphylococcus hyicus is a zoonotic pathogen primarily associated with animal infections. Human infections are exceedingly rare, with only six cases documented in the literature. The pathogen’s role in chronic osteomyelitis of long bones has not been previously reported, presenting unique diagnostic and therapeutic challenges. Case Report We report the first case of chronic osteomyelitis of long bones caused by methicillin-resistant S. hyicus in a 34-year-old male farmer with a history of recurrent osteomyelitis following trauma and livestock exposure. The patient presented with purulent discharge from two fistulae on the medial aspect of the right thigh. Imaging studies revealed bony sequestration, periosteal reaction, and multiple fistulous tracts consistent with Cierny-Mader stage III chronic osteomyelitis. Microbiological identification of coagulase-negative methicillin-resistant S. hyicus was achieved via culture and phenotypic analysis of aspirates from the fistulae and intraoperative samples, with confirmation via matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). A multidisciplinary treatment strategy was implemented, combining extensive surgical debridement and dead space management with a 24-week tailored antibiotic regimen. The regimen included intravenous teicoplanin and ciprofloxacin for 14 days, followed by oral ciprofloxacin and cotrimoxazole. The patient achieved sustained remission with no recurrence at 2.5 years of follow-up. Conclusion This case underscores the zoonotic potential of S. hyicus and highlights its capacity to cause severe, persistent infections in humans, particularly in individuals with occupational or environmental exposure to livestock. Advanced diagnostic techniques such as MALDI-TOF MS are essential for accurate identification, mitigating the risk of misdiagnosis due to phenotypic similarities with other staphylococcal species. Clinicians should consider S. hyicus in the differential diagnosis of chronic osteomyelitis in patients with relevant exposure histories to enable timely and targeted therapeutic interventions.
5 October 2026 in Mediterranean Journal of Infection Microbes and Antimicrobials
Antimicrobial Adverse Events in Periprosthetic Joint Infections: A Narrative Review of Incidence, Drug Class-Specific Toxicities, and Risk Factors - Mediterranean Journal of Infection Microbes and Antimicrobials
Introduction: During the COVID-19 pandemic, healthcare workers (HCWs) were first vaccinated as they were at risk of exposure to SARS-CoV-2. This study aims to assess the immunological responses elicited by COVID-19 vaccines in HCWs, to age, vaccination regimen, and prior COVID-19 infection status. Methods: This prospective study population consisted of HCWs who were administered mRNAbased, adenovirus-based, and inactivated COVID-19 vaccines, in doses ranging from one to three. Blood samples were collected between 3 to 18 months post-final vaccination. Humoral responses were measured using the Elecsys® anti-SARS-CoV-2 S assay, while cellular responses were assessed with the QuantiFERON® SARS-CoV-2 assay. Results and Discussions: Analysis of 44 vaccinated HCWs revealed that 98% had detectable anti-S antibodies, and 75% exhibited detectable cellular responses post-vaccination. Age group, type of vaccine, and the time interval between final vaccination and blood collection did not influence humoral and cellular responses. The number of vaccine doses administered did not correlate with the humoral response. However, a statistically significant positive correlation was observed between levels of CD4 (p=0.029) and CD8 (p=0.015) responses and the number of vaccine doses received. HCWs with two or more previous COVID-19 episodes demonstrated a correlation between the number of vaccine doses given and both humoral (p=0.007) and cellular (p<0.05) responses. Conclusion: Cellular immunity is correlated with the number of vaccine doses administered. HCWs who had encountered two or more COVID-19 episodes exhibited a positive correlation between their immune response and the number of vaccine doses administered.